Hoffmann-La Roche
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
-
- Breast Cancer Treatment Studies
Papers in ⓘ
- Oncology 10
- Cancer Treatment and Pharmacology 10
- Cancer Diagnosis and Treatment 3
- Colorectal Cancer Treatments and Studies 2
-
- Breast Cancer Treatment Studies 7
- Co-authors
- A Boneu (2 shared papers)Georges Houin (2 shared papers)Pierre Canal (2 shared papers)R. Bugat (2 shared papers)Christine Chevreau (1 shared paper)Étienne Chatelut (2 shared papers)A. Pujol (2 shared papers)R. Paridaens (1 shared paper)
In The Last Decade
Hoffmann-La Roche
15 papers receiving 423 citations
Peers
Comparison fields: 5 of 63
- Oncology 256
- Cancer Research 125
- Pathology and Forensic Medicine 132
- Genetics 113
- Reproductive Medicine 26
Countries citing papers authored by Hoffmann-La Roche
This map shows the geographic impact of Hoffmann-La Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoffmann-La Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoffmann-La Roche more than expected).
Fields of papers citing papers by Hoffmann-La Roche
This network shows the impact of papers produced by Hoffmann-La Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoffmann-La Roche. The network helps show where Hoffmann-La Roche may publish in the future.
Co-authors
The 25 scholars most cited alongside Hoffmann-La Roche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 187 | |
| 2 | 1997 | 119 | |
| 3 | 2009 | 39 | |
| 4 | 2009 | 32 | |
| 5 | In vivo measurement of transepidermal water loss | 1978 | 17 |
| 6 | 1996 | 14 | |
| 7 | 2010 | 8 | |
| 8 | Combined results of 4 phase I and pharmacokinetic (PK) studies of E7070, a novel chloroindolyl-sulphonamide inhibiting the activation of cdk2 and cyclin E | 2000 | 7 |
| 9 | 2007 | 5 | |
| 10 | 2007 | 5 | |
| 11 | [Prediction of carboplatin clearance from morphological and biological patient characteristics]. | 1995 | 4 |
| 12 | 2006 | 3 | |
| 13 | 2008 | 2 | |
| 14 | 2009 | 2 | |
| 15 | 1997 | 2 |
About Hoffmann-La Roche
Hoffmann-La Roche is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Pharmaceutical Science, having authored 15 papers that have together received 446 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (7 papers), Cancer Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Advanced Breast Cancer Therapies (2 papers), Estrogen and related hormone effects (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Oncology (256 citations), Cancer Research (125 citations), Pathology and Forensic Medicine (132 citations), Genetics (113 citations) and Reproductive Medicine (26 citations). Hoffmann-La Roche has collaborated with scholars based in France, Belgium and Australia. Frequent co-authors include A Boneu, Georges Houin, Pierre Canal, R. Bugat, Christine Chevreau, Étienne Chatelut, A. Pujol, R. Paridaens, D. Serin and Beat Thürlimann. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, JNCI Journal of the National Cancer Institute, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.